Graham Capital Management L.P. lessened its holdings in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 57.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 57,861 shares of the medical research company’s stock after selling 79,320 shares during the quarter. Graham Capital Management L.P.’s holdings in NeoGenomics were worth $930,000 as of its […]
Swiss National Bank raised its position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 7.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 277,700 shares of the medical research company’s stock after buying an additional 18,800 shares during the quarter. […]
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 1 year […]